{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:17:30Z","timestamp":1778224650894,"version":"3.51.4"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PPA"],"DOI":"10.2147\/ppa.s20791","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T00:05:48Z","timestamp":1432080348000},"page":"675","source":"Crossref","is-referenced-by-count":20,"title":["An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations"],"prefix":"10.2147","author":[{"given":"Barbara","family":"Kornek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,5]]},"container-title":["Patient Preference and Adherence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=25114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:35:54Z","timestamp":1477866954000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/an-update-on-the-use-of-natalizumab-in-the-treatment-of-multiple-scler-peer-reviewed-article-PPA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ppa.s20791","relation":{},"ISSN":["1177-889X"],"issn-type":[{"value":"1177-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}